CLINICAL_TRIALS ClinicalTrials.gov record update

Study to Assess and Compare the Immunogenicity and Reactogenicity of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (INFANRIX™ HEXA) and Aventis Pasteur MSD's DTPa-HBV-IPV-Hib Vaccine (HEXAVAC™) Given at 3, 5 and 11-12 Months of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01457547
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:09.263344+00:00
Published At: 2016-08-05T00:00:00+00:00
Record Updated At: 2016-08-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis B", "Poliomyelitis", "Diphtheria", "Acellular Pertussis", "Tetanus", "Haemophilus Influenzae Type b"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-08-05"
protocolSection.identificationModule.nctId: "NCT01457547"
protocolSection.identificationModule.officialTitle: "Study to Assess and Compare the Immunogenicity and Reactogenicity of GlaxoSmithKline Biologicals\u0027 DTPa-HBV-IPV/Hib Vaccine (INFANRIX\u2122 HEXA) and Aventis Pasteur MSD\u0027s DTPa-HBV-IPV-Hib Vaccine (HEXAVAC\u2122) Given at 3, 5 and 11-12 Months of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.